ArticleLife (Basel, Switzerland)2022

Comparison of Clinical Efficacy and Safety between 70-150 µm and 100-300 µm Doxorubicin Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma.

Jung Woo Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.